The Attributable Direct Medical Cost of Healthcare Associated Infection Caused by Multidrug Resistance Organisms in 68 Hospitals of China

Author:

Jia Huixue1,Li Weiguang2,Hou Tieying3,Ma Hongqiu4,Yang Yun5,Wu Anhua6,Liu Yunxi7,Wen Jianguo8,Yang Huai9,Luo Xiaoli10,Xing Yawei11,Zhang Weihong12,Wu Yinghong13,Ding Lili14,Liu Weiping15,Lin Ling16,Li Ying1,Chen Meilian1,Li Liuyi1ORCID

Affiliation:

1. Peking University First Hospital, Beijing 100034, China

2. Shandong Provincial Hospital, Jinan 250021, China

3. Guangdong General Hospital, Guangzhou 510008, China

4. The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

5. The First Hospital, Shanxi Medical University, Taiyuan 030001, China

6. Xiangya Hospital, Central South University, Changsha 410008, China

7. General Hospital of PLA, Beijing 100853, China

8. The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

9. Guizhou Provincial People’s Hospital, Guiyang 550002, China

10. Jiangxi Province Children’s Hospital, Nanchang 330006, China

11. Fourth Hospital of Hebei Medical University, Shijiazhuang 050019, China

12. Jiangsu Province Hospital, Nanjing 210029, China

13. Peking University People’s Hospital, Beijing 100044, China

14. The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China

15. Inner Mongolia People’s Hospital, Hohhot 010017, China

16. Heilongjiang Province Center for Disease Control and Prevention, Harbin 150030, China

Abstract

Healthcare associated infection (HAI) is known to increase the economic burden of patients while the medical cost due to MDRO HAI is even higher. Three hundred eighty-one multidrug resistance organisms (MDROs) healthcare associated infection (HAI) case-patients and three hundred eighty-one matched control-patients were identified between January and December in 2015. The average total hospitalization medical cost of the case group was $6127.65 and that of the control group was $2274.02. The difference between the case group and the control group was statistically significant (t = 21.07; P < 0.01). The attributable cost of MDRO HAI was $3853.63. The direct medical costs due to different MDRO infections were different. The increased medical costs of CR-AB, CR-KP, and CR-PA were significantly higher than that of MRSA, MRSE, ESBL E. coli, and ESBL Kp (P < 0. 05). Among the subitem expenses, the drug cost increased the most (the average cost was $1457.72), followed by the treatment fee and test fee; the differences were statistically significant (P < 0.01).

Publisher

Hindawi Limited

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3